HOME >> MEDICINE >> NEWS
Cholesterol-lowering drugs not associated with increased breast cancer risk

PITTSBURGH A report being published in the Journal of the National Cancer Institute found that women who took statins--the widely used cholesterol lowering drugs--do not face an increased breast cancer risk as had been suggested by some previous studies. In fact, the study, which was led by a researcher at the University of Pittsburgh Graduate School of Public Health (GSPH), found that women who took hydrophobic statins, named for their inability to dissolve readily in water, had an almost one-fifth lower incidence of invasive breast cancer compared to women who did not take statins.

"At minimum, our findings suggest that women can now be reassured that they are not increasing their risk of developing breast cancer by taking these drugs," said senior author Jane Cauley, Dr.P.H., professor and vice chair for research, department of epidemiology, GSPH. "Although we found that women who took hydrophobic statins actually lowered their breast cancer risk, we believe this finding needs to be confirmed in additional studies."

Dr. Cauley and her co-workers, representing several other research institutions, obtained their findings by analyzing breast cancer incidence over an almost seven-year period among more than 156,000 women enrolled in the long-running Women's Health Initiative study. Of this group of post-menopausal women, 11,710 were statin users; with about 30 percent taking a hydrophilic, or water soluble, statin, and the remaining 70 percent taking a hydrophobic statin.

During the follow-up period, 4,483 women in the study were diagnosed with invasive breast cancer. When the research team examined statins as a class, they found no statistically significant association between statin use and breast cancer incidence, although statin users did tend to have somewhat lower breast cancer rates than non-statin users. Breast cancer incidence also was not associated with how long statins were used. Moreover, use of post-menopausal hormone therapy di
'"/>


16-May-2006


Page: 1 2

Related medicine news :

1. Cholesterol-lowering drugs reduce risk of stroke, heart attack
2. Cholesterol-lowering drugs may be useful in an influenza pandemic
3. UIC researchers to develop new drugs to fight bioterrorism
4. Statin drugs may delay progressive artery damage in children
5. Study finds HIV protease inhibitor drugs may adversely affect the scaffolding of the cell nucleus
6. Experts call for urgent research into anti-epileptic drugs given to children
7. UCLA researchers develop new nanomaterials to deliver anti-cancer drugs to cells
8. Antipsychotic drugs increase risk of death in older people with dementia
9. Antipsychotic drugs increase risk of death in older people with dementia
10. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients
11. Panel offers guidelines on skin reactions to new class of cancer drugs

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/20/2019)... ... March 20, 2019 , ... Confluent ... (BRPT-Lake), a physical therapist owned outpatient physical and occupational therapy practice with seven ... Physical Therapy was founded more than 55 years ago, our mission has been ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... Santa Clara County, announced that the National Committee for Quality Assurance (NCQA) has ... of business. NCQA is a private, not-for-profit organization dedicated to improving health care ...
(Date:3/20/2019)... ... March 20, 2019 , ... Many companies are ... for safe clinical testing. , A recent publication in the Journal of Stem ... Inc. that has shown promising results for the reversal of aging. The paper, ...
(Date:3/20/2019)... Ohio (PRWEB) , ... March 20, 2019 , ... ... or back pain from disc herniation's, degenerative disc disease, spinal stenosis, sciatica ... all in one location! , At Advanced Spine Joint and Wellness provider's ...
(Date:3/20/2019)... ... March 20, 2019 , ... ... its Crominex®3+, a composition of trivalent chromium chloride combined with extracts of amla ... function. This newly granted patent, along with 7 clinical studies on Crominex®3+, establish ...
Breaking Medicine News(10 mins):
(Date:3/20/2019)... ... March 20, 2019 , ... ... which lung cancer patients will respond to chemotherapy, according to a new study ... typically the first-line treatment of advanced-stage non–small cell lung cancer (NSCLC). However, only ...
(Date:3/20/2019)... ... March 20, 2019 , ... SmartLinx, ... Care Centre used its SmartLinx suite to refute a false allegation and immediately ... the Illinois Department of Public Health regulators alleged the facility was out of ...
(Date:3/19/2019)... ... March 19, 2019 , ... TreTap Launches First-Ever CBD Infused ... week online contest – One winner will receive TreTap beverages for a year ... CBD infused maple water beverage. Tretap, which was acquired by Vermont’s original CBD store ...
Breaking Medicine Technology:
Cached News: